REBELS TO WITHDRAW FROM KEY DR CONGO TOWN 'AFTER US REQUEST'. (PHOTO)

Image
 Rebels to withdraw from key DR Congo town 'after US request' The M23 rebel group has said it would withdraw from the eastern DR Congo town of Uvira at the request of the US administration, which had criticised seizure of the town last week as a threat to mediation efforts. The rebels entered Uvira, on the border with Burundi, less than a week after the presidents of Congo and Rwanda met with US President Donald Trump in Washington and affirmed their commitment to a peace deal known as the Washington Accords. US Secretary of State Marco Rubio said on Saturday that Rwanda's actions in eastern Congo violated the Washington Accords and vowed to "take action to ensure promises made to the President are kept." A report by a United Nations group of experts in July said Rwanda exercised command and control over the rebels. Rwanda denies supporting M23 and has blamed Congolese and Burundian forces for the renewed fighting. Corneille Nangaa, leader of the Congo River Allia...

LUTH, SCFN INTRODUCE BONE MARROW TRANSPLANT TO CURE SICKLE CELL DISEASE IN NIGERIA. (PHOTO)

 


LUTH, SCFN INTRODUCE BONE MARROW TRANSPLANT TO CURE SICKLE CELL DISEASE IN NIGERIA


The Lagos University Teaching Hospital (LUTH) and the Sickle Cell Foundation Nigeria (SCFN) have joined forces to introduce a bone marrow transplant program aimed at curing sickle cell disease in Nigeria.


In a statement signed by the Chief Medical Director of LUTH, Prof. Wasiu Adeyemo, and the National Director of SCFN, Dr. Annette Akinsete, they emphasized the urgent need for the program.


According to the statement,“Recognising the gaps in care for individuals affected by the disease in Nigeria, SCFN and LUTH established a bone marrow transplant programme at LUTH.” 


The program includes comprehensive care programs such as newborn screening, penicillin prophylaxis, and Transcranial Doppler screening in children to identify those at risk of stroke.


The statement also noted that the first patients have started undergoing bone marrow transplants at LUTH, receiving treatment to prepare them for the infusion of bone marrow stem cells harvested from family donors.


It stated that, “They received a treatment regimen of exchange blood transfusions, chemotherapy, and anti-infective prophylaxis to prepare them for the infusion of bone marrow stem cells harvested from family donors.”


The stem cell infusions took place on September 17 and September 19, 2024. Currently, both patients are receiving immediate post-transplant care within the transplant unit at LUTH.


Sickle cell disease is a major health challenge in Nigeria, leading to life-threatening complications, organ damage, and reduced life expectancy for those affected. However, with this initiative of LUTH and SCFN, a medical breakthrough is in sight for patients of the disease in Nigeria

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.